Welcome to Dwaey, specifically on Nalidixic Acid page.
This medicine contains important and useful components, as it consists of
Nalidixic Acid is available in the market in concentration.
Nalidixic Acid
Before using Nalidixic Acid, it is essential for patients to consult their healthcare provider to ensure that the medication is appropriate for their condition. Key precautions include:
- Tendon and joint problems: Nalidixic Acid, as a member of the fluoroquinolone class of antibiotics, may cause tendonitis or tendon rupture, particularly in older adults or those concurrently using corticosteroids. Patients should report any pain, swelling, or inflammation in tendons, especially around the Achilles tendon.
- Renal impairment: Patients with renal impairment should use Nalidixic Acid with caution, as it is primarily excreted through the kidneys. Dose adjustments may be necessary to prevent the accumulation of the drug, which could increase the risk of side effects.
- Seizures: Nalidixic Acid may lower the seizure threshold, leading to an increased risk of seizures in susceptible individuals. Those with a history of seizures or other central nervous system (CNS) disorders should be monitored closely while on this medication.
- Hypersensitivity reactions: Rare, but severe allergic reactions, including anaphylaxis, can occur. Signs of hypersensitivity may include rash, itching, swelling, or difficulty breathing. Immediate medical attention should be sought if any of these symptoms appear.
- Pregnancy and breastfeeding: Nalidixic Acid is classified as a Category C drug during pregnancy, meaning it should be used only if the potential benefits outweigh the risks to the fetus. It is unknown if Nalidixic Acid passes into breast milk, so it should be used with caution in breastfeeding mothers.
- Glucose abnormalities: There have been reports of hypoglycemia or hyperglycemia in some patients taking Nalidixic Acid, especially those with diabetes or those taking insulin. Blood sugar levels should be monitored regularly in diabetic patients.
Nalidixic Acid is primarily indicated for the treatment of infections caused by susceptible bacteria. Its indications include:
- Urinary tract infections (UTIs): Nalidixic Acid is commonly used for the treatment of uncomplicated urinary tract infections, such as cystitis, caused by Escherichia coli and other Gram-negative organisms. It is effective in cases where first-line antibiotics may not be appropriate or when patients have a penicillin allergy.
- Infections of the gastrointestinal tract: It is sometimes used for infections caused by Salmonella, Shigella, or Campylobacter, although it is not the first choice for these conditions.
- Other bacterial infections: Nalidixic Acid is occasionally used in the treatment of other bacterial infections where susceptibility testing shows the pathogen to be sensitive to the drug.
Nalidixic Acid is contraindicated in the following situations:
- Hypersensitivity: Patients with a known allergy to Nalidixic Acid or any of its components should avoid the medication.
- Tendon disorders: Nalidixic Acid should not be used in patients with a history of tendon disorders, such as previous tendon ruptures, due to the increased risk of tendonitis and tendon rupture associated with quinolone drugs.
- Severe renal impairment: Patients with severe renal impairment should not use Nalidixic Acid unless the benefits clearly outweigh the risks, as the drug is excreted primarily by the kidneys, and impaired renal function may increase the risk of toxicity.
- Pregnancy and breastfeeding: Nalidixic Acid is not recommended during pregnancy (Category C) unless absolutely necessary, and should be avoided during breastfeeding as it may pass into the milk, potentially affecting the infant.
As with any medication, Nalidixic Acid can cause side effects. Some common and severe side effects include:
- Common side effects:
- Gastrointestinal disturbances: Patients may experience nausea, vomiting, or abdominal discomfort.
- Headache and dizziness: These are common, especially in older adults.
- Rash: Some patients may develop a mild skin rash or itching.
- Serious side effects:
- Tendonitis and tendon rupture: These serious side effects, including Achilles tendon rupture, are more likely in older adults, patients on corticosteroids, and those with renal impairment. Discontinuation of the drug should be considered if tendon pain or inflammation occurs.
- Severe allergic reactions: Rarely, patients may experience anaphylaxis, a life-threatening allergic reaction that may include swelling, difficulty breathing, or hypotension.
- Seizures: Nalidixic Acid can lower the seizure threshold, which may result in convulsions, particularly in patients with a history of seizure disorders.
- Peripheral neuropathy: Long-term use of Nalidixic Acid may lead to nerve damage, causing symptoms such as tingling, numbness, or weakness in the extremities.
- CNS toxicity: Confusion, hallucinations, or agitation can occur, particularly in elderly patients.
- Photosensitivity: Nalidixic Acid can increase sensitivity to sunlight, leading to an increased risk of sunburn. Patients should avoid excessive sun exposure or use sunscreen while on this medication.
3
Nalidixic Acid is an antibiotic that belongs to the quinolone class. It works by inhibiting DNA gyrase and topoisomerase IV, enzymes responsible for supercoiling and uncoiling the DNA of bacteria. By interfering with these processes, Nalidixic Acid prevents bacterial DNA replication, transcription, and repair, ultimately leading to bacterial cell death.
- Bactericidal effect: Nalidixic Acid is bactericidal, meaning it kills bacteria rather than simply inhibiting their growth.
- Broad-spectrum activity: It is effective against a variety of Gram-negative bacteria, including Escherichia coli, Klebsiella, and Proteus species, as well as some Gram-positive organisms.
Although effective against many pathogens, Nalidixic Acid has limited activity against aerobic Gram-positive bacteria and is less potent than newer fluoroquinolones, which are used for a broader range of infections.
Nalidixic Acid may interact with other medications, which can affect its efficacy or increase the risk of side effects. Notable interactions include:
- Antacids: Antacids containing magnesium, aluminum, or iron supplements may decrease the absorption of Nalidixic Acid. Patients should avoid taking these products within 2 hours of Nalidixic Acid.
- Warfarin: Nalidixic Acid may enhance the effects of warfarin, increasing the risk of bleeding. Patients on warfarin should have their prothrombin time (INR) monitored frequently during treatment with Nalidixic Acid.
- Corticosteroids: The concurrent use of corticosteroids and Nalidixic Acid increases the risk of tendonitis or tendon rupture, particularly in elderly patients. This combination should be used cautiously and only when necessary.
- Other antibiotics: When used with other antibiotics that have similar mechanisms of action, the risk of resistance may increase. It is important to assess the need for combined therapy and select appropriate antibiotics based on susceptibility testing.
- Cyclosporine: Cyclosporine may increase the concentration of Nalidixic Acid in the body, increasing the risk of toxicity. Dose adjustments may be necessary for both drugs.
The typical dose of Nalidixic Acid for adults is:
- For urinary tract infections (UTIs): The usual dose is 1 gram (1000 mg) orally every 6 hours, for a total of 4 grams per day. The treatment duration typically lasts for 7 to 14 days, depending on the severity of the infection and the patient's response to therapy.
- For other bacterial infections: The dosage may vary, and patients should follow the dosing instructions provided by their healthcare provider.
Nalidixic Acid is not typically recommended for use in children, particularly due to concerns over the potential impact on cartilage development in growing bones. If prescribed to children, the dosing should be based on weight and severity of the infection, and close monitoring for side effects is necessary.
For children aged 3 years and older, the usual dose is 15 mg/kg orally every 6 hours, up to a maximum of 1 gram per dose. However, this should only be used under the direction of a pediatrician.
It is always crucial for patients to consult with their healthcare provider prior to starting Nalidixic Acid to ensure it is safe and appropriate for their individual circumstances.
In patients with renal impairment, the dose of Nalidixic Acid may need to be reduced due to decreased clearance. Patients with creatinine clearance (CrCl) less than 50 mL/min should generally receive a reduced dose or a longer interval between doses to minimize the risk of drug accumulation and toxicity.
For severe renal impairment, dose adjustments should be made carefully, and frequent monitoring is advised.